Literature DB >> 3222488

Reference dose (RfD): description and use in health risk assessments.

D G Barnes1, M Dourson.   

Abstract

For many years the concept of the "acceptable daily intake" has served the toxicological and regulatory fields quite well. However, as approaches to assessing the health significance of exposures to noncarcinogenic substances receive greater scrutiny, some difficulties with this traditional approach have become more apparent. Consequently, the concept of the "reference dose" is introduced in order to avoid use of prejudicial terms (e.g., "safety" and "acceptable"), to promote greater consistency in the assessment of noncarcinogenic chemicals, and to maintain the functional separation between risk assessment and risk management.

Mesh:

Substances:

Year:  1988        PMID: 3222488     DOI: 10.1016/0273-2300(88)90047-5

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  55 in total

1.  Low dose exposure to natural and man made fibres and the risk of cancer: towards a collaborative European epidemiology. Report of a workshop held in Paris , 10-12 June, 1991.

Authors:  A J Valleron; J Bignon; J M Hughes; T W Hesterberg; T Schneider; G J Burdett; P Brochard; D Hémon
Journal:  Br J Ind Med       Date:  1992-09

2.  Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice.

Authors:  Takashi Mori; Naoki Koyama; Tatsuya Segawa; Masahiro Maeda; Nobuhiro Maruyama; Noriaki Kinoshita; Huayan Hou; Jun Tan; Terrence Town
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

3.  Air quality and deposition of trace elements in Didouche Mourad, Algeria.

Authors:  H Ali-Khodja; A Belaala; W Demmane-Debbih; B Habbas; N Boumagoura
Journal:  Environ Monit Assess       Date:  2007-06-12       Impact factor: 2.513

4.  Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice.

Authors:  Takashi Mori; Naoki Koyama; Jun Tan; Tatsuya Segawa; Masahiro Maeda; Terrence Town
Journal:  J Biol Chem       Date:  2018-12-18       Impact factor: 5.157

5.  Residue decline and risk assessment of fluopyram + tebuconazole (400SC) in/on onion (Allium cepa).

Authors:  Badal V Patel; Suchi Chawla; Hetal Gor; Payal Upadhyay; Kaushik D Parmar; Anil R Patel; Paresh G Shah
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-03       Impact factor: 4.223

6.  Characterizing Risk for Cumulative Risk Assessments.

Authors:  Margaret M MacDonell; Richard C Hertzberg; Glenn E Rice; J Michael Wright; Linda K Teuschler
Journal:  Risk Anal       Date:  2017-11-23       Impact factor: 4.000

Review 7.  The use of toxicokinetics for the safety assessment of drugs acting in the brain.

Authors:  D B Campbell
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

8.  A Case Study Application of the Aggregate Exposure Pathway (AEP) and Adverse Outcome Pathway (AOP) Frameworks to Facilitate the Integration of Human Health and Ecological End Points for Cumulative Risk Assessment (CRA).

Authors:  David E Hines; Stephen W Edwards; Rory B Conolly; Annie M Jarabek
Journal:  Environ Sci Technol       Date:  2017-12-29       Impact factor: 9.028

9.  Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease.

Authors:  Takashi Mori; Naoki Koyama; Jun Tan; Tatsuya Segawa; Masahiro Maeda; Terrence Town
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

10.  Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.

Authors:  Takashi Mori; Naoki Koyama; Tomotaka Yokoo; Tatsuya Segawa; Masahiro Maeda; Darrell Sawmiller; Jun Tan; Terrence Town
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.